Company / Profit Margin
ANI Pharmaceuticals, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
8.9%
FY2025
5-year range
-19.7% / 8.9%
FY2021-FY2025
Trend
+394.7%
vs FY2024
Sector context
#40 of 146
Health Care
What the data says
Profit Margin changed +395% YoY in FY2025, a notable deviation from the 9-year average annual change of +153%.
Based on SEC 10-K filings.
8.9% in FY2025 with a 5-year CAGR of +19.7%.
Improved from 3.9% to 8.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +24.0pp
- 5-Year Change
- +19.7pp
- 10-Year Change
- -
Sector benchmark
#40 of 146 in Health CareTop 27% of 146This company 8.9% Sector average -796.3%
▼
+101.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 394.7% year-over-year.
- Currently 805.1pp above the Health Care sector average.
- Peak profit margin was recorded in FY2019.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.9% | +394.7% |
| FY2024 | -3.0% | -178.0% |
| FY2023 | 3.9% | +125.5% |
| FY2022 | -15.1% | +23.2% |
| FY2021 | -19.7% | -82.2% |
| FY2020 | -10.8% | -193.9% |
| FY2019 | 11.5% | +49.8% |
| FY2018 | 7.7% | +1360.7% |
| FY2017 | -0.6% | -119.9% |
| FY2016 | 3.1% | +206.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026